Skip to main content
University of California San Francisco
UCSF School of Medicine | Department of Pediatrics UCSF Medical Center

Logistics, risks, and benefits of automated red blood cell exchange for patients with sickle cell disease.

  • Read more about Logistics, risks, and benefits of automated red blood cell exchange for patients with sickle cell disease.

Too many white cells-TAM, JMML, or something else?

  • Read more about Too many white cells-TAM, JMML, or something else?

Evolving treatment paradigms in sickle cell disease.

  • Read more about Evolving treatment paradigms in sickle cell disease.

Chronic organ failure in adult sickle cell disease.

  • Read more about Chronic organ failure in adult sickle cell disease.

Emerging 'A' therapies in hemoglobinopathies: agonists, antagonists, antioxidants, and arginine.

  • Read more about Emerging 'A' therapies in hemoglobinopathies: agonists, antagonists, antioxidants, and arginine.

Alpha thalassemia major--new mutations, intrauterine management, and outcomes.

  • Read more about Alpha thalassemia major--new mutations, intrauterine management, and outcomes.

Non-invasive assessment of tissue iron overload.

  • Read more about Non-invasive assessment of tissue iron overload.

Hemoglobin e syndromes.

  • Read more about Hemoglobin e syndromes.

Stem cell therapy for sickle cell disease: transplantation and gene therapy.

  • Read more about Stem cell therapy for sickle cell disease: transplantation and gene therapy.

Thalassemia.

  • Read more about Thalassemia.

Pagination

  • Page 1
  • Next page ››
Subscribe to Hematology. American Society of Hematology. Education Program

Pediatrics Home

MAKE A GIFT

© 2022 The Regents of the University of California. The University of California San Francisco  |  UCSF Department of Pediatrics                                                                                              Accessibility  Privacy Policy  Terms of Use  A-Z Website List